Overview

Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage

Status:
Unknown status

Trial end date:
2008-11-01

Target enrollment:

Participant gender:

Summary

To evaluate the role of lactulose in prevention of clinically overt hepatic encephalopathy (HE) in the setting of acute upper gastrointestinal bleeding in cirrhotic patients

Phase:

Phase 3

Details

Lead Sponsor:

Aga Khan University

Treatments:

Lactulose